Caray, Baby Girl .
HRN: 21-99-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/20/2022
11/27/2022
IV
50 Mg
Q24
PSNB (Maternal UTI, Chorioamnionitis) RDS Vs MAS
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes